RIC Stroke Research Trial Touted as Key to Senator Kirk’s Recovery - Rehabilitation Institute of Chicago

Skip to Content

Published on August 13, 2012

RIC Stroke Research Trial Touted as Key to Senator Kirk’s Recovery

WASHINGTON—The Rehabilitation Institute of Chicago (RIC) was featured in a Washington Post article on Saturday, Aug. 11, that attributed U.S. Senator Mark Kirk’s “remarkable” recovery to RIC’s unique walking trial – one of more than 300 research projects underway at RIC.

Senator Kirk recently released a second video that documents his continued recovery from a stroke he had earlier this year. 

Read more about this unique research trial here.

About the Rehabilitation Institute of Chicago

The Rehabilitation Institute of Chicago (RIC) is the nation’s top-ranked provider of comprehensive physical medicine and rehabilitation care to patients from around the world. Ranked #1 by both U.S. News and World Report and the U.S. National Institutes of Health, RIC holds an unparalleled market distinction.

With a record eight multi-year, multi-million dollar federal research designations awarded and funded by the National Institutes of Health and the Department of Education’s National Institute of Disability and Rehabilitation Research in the areas of spinal cord injury, brain injury, stroke, neurological rehabilitation, outcomes research, bionic medicine/rehabilitation engineering research, and pediatric orthopedics, RIC operates the largest rehabilitation research enterprise in the world.

RIC also operates its 182-bed, flagship hospital in downtown Chicago, as well as a network of more than 40 sites of care distributed throughout the Midwest, through which it delivers inpatient, day rehabilitation, and outpatient services.

Founded in 1954, RIC has been designated the “#1 Rehabilitation Hospital in America” by U.S. News & World Report every year since 1991. RIC sets the standard of care in the post-acute market through its innovative applied research and discovery programs, particularly in the areas of neuroscience, bionic medicine, musculoskeletal medicine and technology transfer. For more information, go to www.ric.org.

Journalists contact: mediarelations@ric.org, 312-238-4571.

All others contact: webmaster@ric.org.